DexCom, Inc.
DXCM
$73.43
-$0.95-1.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.26B | 1.21B | 1.16B | 1.04B | 1.11B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.26B | 1.21B | 1.16B | 1.04B | 1.11B |
| Cost of Revenue | 466.90M | 477.90M | 468.30M | 447.00M | 457.70M |
| Gross Profit | 792.70M | 731.40M | 688.80M | 589.00M | 655.80M |
| SG&A Expenses | 321.50M | 331.40M | 328.00M | 310.10M | 327.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 936.60M | 966.80M | 944.50M | 902.30M | 924.60M |
| Operating Income | 323.00M | 242.50M | 212.60M | 133.70M | 188.90M |
| Income Before Tax | 340.70M | 352.30M | 241.10M | 154.30M | 211.30M |
| Income Tax Expenses | 73.40M | 68.50M | 61.30M | 48.90M | 59.60M |
| Earnings from Continuing Operations | 267.30M | 283.80M | 179.80M | 105.40M | 151.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 267.30M | 283.80M | 179.80M | 105.40M | 151.70M |
| EBIT | 323.00M | 242.50M | 212.60M | 133.70M | 188.90M |
| EBITDA | 388.20M | 306.10M | 275.60M | 193.70M | 246.70M |
| EPS Basic | 0.69 | 0.73 | 0.46 | 0.27 | 0.39 |
| Normalized Basic EPS | 0.55 | 0.56 | 0.38 | 0.25 | 0.34 |
| EPS Diluted | 0.68 | 0.70 | 0.45 | 0.27 | 0.38 |
| Normalized Diluted EPS | 0.53 | 0.54 | 0.37 | 0.24 | 0.32 |
| Average Basic Shares Outstanding | 386.70M | 391.10M | 392.10M | 391.10M | 390.60M |
| Average Diluted Shares Outstanding | 398.90M | 407.40M | 408.20M | 407.50M | 406.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |